Medications and vocational rehabilitation are both integral to the recovery
process for schizophrenia. The development of new medications for schizoph
renia, combined with promising research on supported employment, has led to
renewed attention to the interrelationship between the two. These new medi
cations have fewer motor side effects and greater impact on cognitive funct
ioning than traditional medications. Consequently, they are hypothesized to
enable more consumers to benefit from rehabilitation programs and to obtai
n competitive jobs, More rigorous research is needed in all of these areas,
Suggestions are offered to-rehabilitation professionals regarding the role
of medications in employment.